ICU Medical, Inc. (ICUI) Tops Q2 EPS by 11c, Raises FY11 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts ICUI Hot Sheet
Price: $160.84 -0.15%
Revenue Growth %: +2.8%
Financial Fact:
Total operating expenses: 28.82M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Revenue Growth %: +2.8%
Financial Fact:
Total operating expenses: 28.82M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
ICU Medical, Inc. (NASDAQ: ICUI) reported Q2 EPS of $0.67, $0.11 better than the analyst estimate of $0.56. Revenue for the quarter came in at $77.8 million versus the consensus estimate of $74.24 million.
The company raised its FY11 revenue guidance to $297 million to $305 million, compared to its previous range of $295 million to $305 million. The Street is currently looking for $306.7 million.
The company also raised its FY11 EPS range to $2.35 to $2.50 per share, compared to its previous range of $2.30 to $2.50 per share. The consensus is $2.45.
Operating cash flow is expected to be in the range of $45 million to $50 million.
The company raised its FY11 revenue guidance to $297 million to $305 million, compared to its previous range of $295 million to $305 million. The Street is currently looking for $306.7 million.
The company also raised its FY11 EPS range to $2.35 to $2.50 per share, compared to its previous range of $2.30 to $2.50 per share. The consensus is $2.45.
Operating cash flow is expected to be in the range of $45 million to $50 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Integra LifeSciences (IART) Tops Q3 EPS by 3c; offers guidance
- BancFirst Corp. (BANF) Tops Q3 EPS by 3c
- Oceaneering (OII) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
